References
- Aldossary S. Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacology J. 2019;12(1):7–15. DOI:
https://dx.doi.org/10.13005/bpj/1608 https://bit.ly/2HXEUBG - Cui X, Gong J, Han H, He L, Teng Y, Tetley T, Sinharay R, Chung K, Islam T, Gilliland F, Grady S, Garshick E, Li Zh, Zhang J. Relationship between free and total malondialdehyde, a well-established marker of oxidative stress, in various types of human biospecimens. Journal of Thoracic Disease. 2018;10(5):3088–3097. DOI: 10.21037/jtd.2018.05.92
https://jtd.amegroups.org/article/view/21482/html - Dasari S, Njiki S, Mbemi A, Yedjou C, Tchounwou P. Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int. J. Mol. Sci. 2022;23(3),1532: 1–25. [
https://doi.org/10.3390/ijms23031532 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835907/ - Garcia J, Scherer T, Chen J, Guillory B, Nassif A, Papusha V, Smiechowska J, Asnicar M, Buettner C, Smith R. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Endocrinology. 2013;154(9):3118–3129. [DOI: 10.1210/en.2013-1179
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749475/ - Gaschler M, Stockwell B. Lipid peroxidation in cell death. Biochemical and Biophysical Research Communications. 2017;482(3):419–425. doi: 10.1016/j.bbrc.2016.10.086 [
https://pubmed.ncbi.nlm.nih.gov/28212725/ - Gentile F, Arcaro A, Pizzimenti S, Daga M, Cetrangolo G, Dianzani C, Lepore A, Graf M, Ames P, Barrera G. DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity. AIMS Genet. 2017;4(2):103–137. doi: 10.3934/genet.2017.2.103 [
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690246/ - Habtemariam S. Modulation of reactive oxygen species in health and disease. Antioxidants. 2019;8(11):513–516. doi: 10.3390/antiox8110513
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912431/ - Hauck A, Bernlohr D. Oxidative stress and lipotoxicity. Journal of Lipid Research. 2016;57(11):1977–1986. DOI: 10.1194/jlr.R066597
https://pubmed.ncbi.nlm.nih.gov/27009116/ - Jadoon S, Malik A. A review article on the formation, mechanism and biochemistry of MDA and MDA as a biomarker of oxidative stress. Int J Adv. Res. 2017;5(12):811–818. DOI: 10.21474/IJAR01/6024 [
http://dx.doi.org/10.21474/IJAR01/6024 - Jin H, Wang J, Wang Z, Xi M, Xia B, Deng K, Yang J. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. Journal of Hematology & Oncology. 2023;16:103:1–33. [
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01498-2 - Kalb V, Bernlohr R. A new spectrophotometric assay for protein in cell extracts. Anal Biochem. 1977;82(2):362–371. DOI: 10.1016/0003-2697(77)90173-7 [
https://www.sciencedirect.com/science/article/abs/pii/0003269777901737 - Koroliuk M, Ivanova L, Maĭorova I, Tokarev V. A method of determining catalase activity. Lab Delo. 1988;1:16–19. (Published in Russian). [
https://pubmed.ncbi.nlm.nih.gov/2451064/ - Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analyt. Biochem. 1978; 86:271–278. DOI: 10.1016/0003-2697(78)90342-1 [
https://www.sciencedirect.com/science/article/abs/pii/0003269778903421 - Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi S, Ranjbar A, SeyedSaleh S, Sharifzadeh S, Khan H, Ashrafizadeh M, et al. Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies. Molecules. 2021;26:2382:1–37. DOI: 10.3390/molecules26082382 [
https://pubmed.ncbi.nlm.nih.gov/33921908/ - Plathow C, Weber W. Tumor cell metabolism imaging. Journal of Nuclear Medicine. 2008;4(6):43S–63S. DOI:
https://doi.org/10.2967/jnumed.107.045930 [https://jnm.snmjournals.org/content/49/Suppl_2/43S - Singh R, Manna P. Reactive oxygen species in cancer progression and its role in therapeutics. Explore Med. 2022;3:43–57. DOI:
https://doi.org/10.37349/emed.2022.00073 [https://www.explorationpub.com/Journals/em/Article/100173 - Tchounwou P, Dasari S, Noubissi F, Ray P, Kumar S. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J. Exp Pharmacol. 2021;13:308–328. DOI: 10.2147/JEP.S267383
https://pubmed.ncbi.nlm.nih.gov/33776489/ - Valgimigli L. Lipid peroxidation and antioxidant protection. Biomolecules. 2023;13:1291,1–33.
https://doi.org/10.3390/biom13091291 [https://www.mdpi.com/journal/biomolecules - Volchegorsky I, Nalimov A, Yarovinsky B, Livshits R (1989). Comparison of different approaches to the determination of lipid peroxidation products in heptane-isopropanol blood extracts. Vopr. Med. Chime. 1989;35(1): 127–131. (Published in Russian). [
https://www.researchgate.net/publication/20415627 - Yavroyan Zh, Hovhannisyan A, Hakobyan N, Gevorgyan E. Cisplatin and estradiol separate and joint action on catalase activity in liver and kidney tissues of rats. Eurasian Union of Scientists (ESU). 2019;11(68):12–16. [DOI: 10.31618/ESU.2413-9335.2019.2.68.439 [
https://www.researchgate.net/publication/338056613